Lanxess is investing some €60 million in expanding custom synthesis facilities at multi-purpose production facilities in the Central Organics Pilot Plant (ZeTO) of fine chemicals subsidiary Saltigo in Leverkusen, Germany.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International